A rise in popularity in glucagon-like peptide 1 receptor agonists such as Ozempic and Wegovy is causing concern in the medical community over potential side effects for various physician specialties, according to a July 17 report from Medscape.
Weight loss drugs and GI: Side effects providers should know
